LENSAR, Inc.

NASDAQ:LNSR

Medical - Devices

Healthcare
$4.85 -8.15%

-$0.51 today

Market cap
$59.63M
Beta
0.87
P/E (TTM)
2.4
EPS (TTM)
$2.42
52W Low $5.06High $13.47

Volume 0.06M

Average 0.09M

LNSR Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

LENSAR, Inc.NASDAQ: LNSR

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 12.16M shares rose 3.3% year over year, in line with the +3.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at +5.6% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +3.3% toward the trailing-twelve-month pace of +3.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
12.16M+0.7% QoQ
Last fiscal yearDec 2025
11.96M+3.8% YoY
LTMMar 2026
12.05M+3.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.3%——
1 year+3.8%——
3-year CAGR+5.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
11.96M USD
Year-over-year change
+3.8%
4-year CAGR
+6.3%

Weighted Avg Shares vs competitors

How LNSR compares with its peers on the latest reported figures

  • LNSR's LTM Mar 2026 weighted avg shares of 12.05M shares is the lowest of the 10 companies compared; the peer median is 43.59M shares.
  • Its year-over-year change of +3.8% is the 6th highest of 10, against a peer median of +21.2%.
  • Over three fiscal years its annual growth of +5.6% compares with a peer median of +13.2%.
LNSR Competitors Peer median
Weighted Avg Shares for LNSR and competitors
Company Period LTM YoY 3-year CAGR
OWLTOwlet, Inc.LTM Mar 2026149.39M +1085.6%+313.6%
MXCTMaxCyte, Inc.LTM Mar 2026106.51M +1.3%+1.5%
CRDFCardiff Oncology, Inc.LTM Mar 202667.15M +30.5%+15.3%
RPIDRapid Micro Biosystems, Inc.LTM Mar 202644.81M +2.4%+1.7%
TLSITriSalus Life Sciences, Inc.LTM Mar 202643.59M +65.4%+18.4%
PROFProfound Medical Corp.LTM Mar 202631.8M +21.2%+13.2%
AVRAnteris Technologies Global Corp.LTM Mar 202623.58M -20.8%-13.1%
ANIKAnika Therapeutics, Inc.LTM Mar 202614.15M -3.2%-0.5%
CRBPCorbus Pharmaceuticals Holdings, Inc.LTM Mar 202612.8M +30.5%+47.3%
LNSRLENSAR, Inc.LTM Mar 202612.05M +3.8%+5.6%
Peer median (excluding LNSR) 43.59M+21.2%+13.2%

Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue34.46M35.36M42.16M53.49M58.44M
Cost of Revenue16.63M15.4M21.06M27.64M31.31M
Gross Profit17.83M19.96M21.11M25.85M27.12M
Gross Margin51.8%56.4%50.1%48.3%46.4%
Research & Development12.36M11.81M6.14M5.33M5.62M
Selling, General & Admin23.89M27.17M26.1M26.49M45.16M
Operating Expenses37.49M40.13M33.34M36.52M51.7M
Depreciation & Amortization2.76M3.41M3.52M3.93M4.5M
EBITDA(16.84M)(16.51M)(10.87M)(3.01M)(29.78M)
EBITDA Margin-48.9%-46.7%-25.8%-5.6%-51.0%
Operating Income(19.65M)(20.18M)(12.23M)(10.67M)(24.58M)
Operating Margin-57.0%-57.1%-29.0%-19.9%-42.1%
Interest Income34K17K85K103K91K
Interest Expense00000
Other Income / Expenses51K263K(2.15M)(20.74M)(9.7M)
Income Before Tax(19.6M)(19.91M)(14.38M)(31.4M)(34.28M)
Pre-Tax Margin-56.9%-56.3%-34.1%-58.7%-58.7%
Income Tax Expense00000
Net Income(19.6M)(19.91M)(14.38M)(31.4M)(34.28M)
Net Margin-56.9%-56.3%-34.1%-58.7%-58.7%
EPS (Basic)(2.10)(1.96)(1.31)(2.73)(2.87)
EPS (Diluted)(2.10)(1.96)(1.31)(2.73)(2.87)
Weighted Avg Shares9.37M10.16M10.97M11.52M11.96M
Weighted Avg Shares (Diluted)9.37M10.16M10.97M11.52M11.96M

LENSAR, Inc.

NASDAQ:LNSR

Intrinsic Alpha fair value

Locked

Current Price

$4.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.